These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 2121335)
1. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells. Siegel D; Gibson NW; Preusch PC; Ross D Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Siegel D; Gibson NW; Preusch PC; Ross D Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346 [TBL] [Abstract][Full Text] [Related]
3. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Gibson NW; Hartley JA; Butler J; Siegel D; Ross D Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604 [TBL] [Abstract][Full Text] [Related]
4. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells. Qiu XB; Cadenas E Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371 [TBL] [Abstract][Full Text] [Related]
5. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity. Fisher GR; Gutierrez PL Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286 [TBL] [Abstract][Full Text] [Related]
6. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Ross D; Siegel D; Gibson NW; Pacheco D; Thomas DJ; Reasor M; Wierda D Free Radic Res Commun; 1990; 8(4-6):373-81. PubMed ID: 2113030 [TBL] [Abstract][Full Text] [Related]
7. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
8. Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase. OrdoƱez ID; Cadenas E Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):481-90. PubMed ID: 1530580 [TBL] [Abstract][Full Text] [Related]
9. Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase). Fisher GR; Donis J; Gutierrez PL Biochem Pharmacol; 1992 Oct; 44(8):1625-35. PubMed ID: 1301071 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones. Bailey SM; Suggett N; Walton MI; Workman P Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540 [TBL] [Abstract][Full Text] [Related]
12. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinone-acceptor oxidoreductase (DT-diaphorase) and NADPH cytochrome c reductase. Fisher GR; Gutierrez PL Free Radic Biol Med; 1991; 11(6):597-607. PubMed ID: 1663902 [TBL] [Abstract][Full Text] [Related]
13. Modulation of trenimon-induced cytotoxicity by DT-diaphorase in isolated rat hepatocytes under aerobic versus hypoxic conditions. Silva JM; Rao DN; O'Brien PJ Cancer Res; 1992 Jun; 52(11):3015-21. PubMed ID: 1375532 [TBL] [Abstract][Full Text] [Related]
14. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528 [TBL] [Abstract][Full Text] [Related]
15. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Walton MI; Smith PJ; Workman P Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284 [TBL] [Abstract][Full Text] [Related]
16. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Winski SL; Hargreaves RH; Butler J; Ross D Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts. Halinska A; Belej T; O'Brien PJ Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840 [TBL] [Abstract][Full Text] [Related]
18. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin. Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity. Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574 [TBL] [Abstract][Full Text] [Related]
20. Diaziquone-induced cytotoxicity in isolated rat hepatocytes. Silva JM; O'Brien PJ Cancer Res; 1989 Oct; 49(20):5550-4. PubMed ID: 2790779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]